§ Telehealth Basics
Peptide Therapy
Short chains of amino acids (e.g., BPC-157, CJC-1295) marketed for recovery, performance, and longevity.
Fact-checked 12 May 2026Plain-English Reference
Most peptides marketed in telehealth are not FDA-approved for the indications they are sold for. Some (like sermorelin) have a longer history; others (like BPC-157) have minimal human safety data. Patients should ask the source pharmacy, the evidence base, and whether the prescription is on or off label.